Rights and permissions
About this article
Cite this article
Denosumab for osteoporosis: restricted access in Canada. Pharmacoecon. Outcomes News 626, 10 (2011). https://doi.org/10.2165/00151234-201106260-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106260-00028